{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:20:59Z","timestamp":1740144059182,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2162-6","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T07:20:42Z","timestamp":1505892042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Topiramate\u2019s effectiveness on weight reduction in overweight\/obese persons with schizophrenia: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-8228","authenticated-orcid":false,"given":"Miyuru","family":"Chandradasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layani","family":"Champika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silumini","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A. L. A.","family":"Kuruppuarachchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"2162_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","volume":"10","author":"TM Laursen","year":"2014","unstructured":"Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014;10:425\u201348.","journal-title":"Annu Rev Clin Psychol."},{"issue":"3","key":"2162_CR2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","volume":"170","author":"C Crump","year":"2013","unstructured":"Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324\u201333.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2162_CR3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.9758\/cpn.2014.12.2.128","volume":"12","author":"HY Kim","year":"2014","unstructured":"Kim HY, Lee HW, Jung SH, Kang MH, Bae JN, Lee JS, Kim CE. Prescription patterns for patients with schizophrenia in Korea: a focus on antipsychotic polypharmacy. Clin Psychopharmacol Neurosci. 2014;12(2):128\u201336.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"9","key":"2162_CR4","first-page":"593","volume":"87","author":"L Zaghdoudi","year":"2009","unstructured":"Zaghdoudi L, Homri W, Belaid S, Ben Bechir M, Labbane R. Quality of life of patient with schizophrenia treated by conventional and atypical neuroleptics. Tunis Med. 2009;87(9):593\u20138.","journal-title":"Tunis Med"},{"issue":"5","key":"2162_CR5","first-page":"292","volume":"4","author":"HJ Riordan","year":"2011","unstructured":"Riordan HJ, Antonini P, Murphy MF. Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications. Am Health Drug Benefits. 2011;4(5):292\u2013302.","journal-title":"Am Health Drug Benefits"},{"issue":"1-3","key":"2162_CR6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.schres.2015.05.004","volume":"166","author":"A Enez Darcin","year":"2015","unstructured":"Enez Darcin A, Yalcin Cavus S, Dilbaz N, Kaya H, Dogan E. Metabolic syndrome in drug-na\u00efve and drug-free patients with schizophrenia and in their siblings. Schizophr Res. 2015;166(1-3):201\u20136.","journal-title":"Schizophr Res"},{"issue":"3","key":"2162_CR7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.yebeh.2005.01.005","volume":"6","author":"GM Roberts","year":"2005","unstructured":"Roberts GM, Majoie HJ, Leenen LA, Bootsma HP, Kessels AG, Aldenkamp AP, Leonard BE. Ketter\u2019s hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam. Epilepsy Behav. 2005;6(3):366\u201372.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"2162_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","volume":"29","author":"O Howes","year":"2015","unstructured":"Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol. 2015;29(2):97\u2013115.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"2162_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2011.05.014","volume":"95","author":"A Verrotti","year":"2011","unstructured":"Verrotti A, Scaparrotta A, Agostinelli S, Di Pillo S, Chiarelli F, Grosso S. Topiramate-induced weight loss: a review. Epilepsy Res. 2011;95(3):189\u201399.","journal-title":"Epilepsy Res"},{"issue":"4","key":"2162_CR10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3371\/CSRP.HACO.01062013","volume":"6","author":"MK Hahn","year":"2013","unstructured":"Hahn MK, Cohn T, Teo C, Remington G. Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters. Clin Schizophr Relat Psychoses. 2013;6(4):186\u201396.","journal-title":"Clin Schizophr Relat Psychoses"},{"issue":"1-3","key":"2162_CR11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2010.02.001","volume":"118","author":"PK Narula","year":"2010","unstructured":"Narula PK, Rehan HS, Unni KE, Gupta N. Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial. Schizophr Res. 2010;118(1-3):218\u201323.","journal-title":"Schizophr Res"},{"issue":"2","key":"2162_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"issue":"2","key":"2162_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0269881108089816","volume":"23","author":"H Afshar","year":"2009","unstructured":"Afshar H, Roohafza H, Mousavi G, Golchin S, Toghianifar N, Sadeghi M, Talaei M. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial. J Psychopharmacol. 2009;23(2):157\u201362.","journal-title":"J Psychopharmacol"},{"issue":"5","key":"2162_CR14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/acps.12631","volume":"134","author":"W Zheng","year":"2016","unstructured":"Zheng W, Xiang YT, Xiang YQ, Li XB, Ungvari GS, Chiu HF, Correll CU. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials. Acta Psychiatr Scand. 2016;134(5):385\u201398.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"2162_CR15","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.4088\/JCP.15r10373","volume":"77","author":"CU Correll","year":"2016","unstructured":"Correll CU, Maayan L, Kane J, Hert MD, Cohen D. Efficacy for psychopathology and body weight and safety of topiramate-antipsychotic cotreatment in patients with schizophrenia spectrum disorders: results from a meta-analysis of randomized controlled trials. J Clin Psychiatry. 2016;77(6):e746\u201356.","journal-title":"J Clin Psychiatry"},{"key":"2162_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000354952","volume":"78","author":"A Misra","year":"2014","unstructured":"Misra A, Bhardwaj S. Obesity and the metabolic syndrome in developing countries: focus on South Asians. Nestle Nutr Inst Workshop Ser. 2014;78:133\u201340.","journal-title":"Nestle Nutr Inst Workshop Ser."},{"issue":"11","key":"2162_CR17","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/106002809703101114","volume":"31","author":"EJ Frackiewicz","year":"1997","unstructured":"Frackiewicz EJ, Sramek JJ, Herrera JM, Kurtz NM, Cutler NR. Ethnicity and antipsychotic response. Ann Pharmacother. 1997;31(11):1360\u20139.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2162_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12889-017-4041-1","volume":"17","author":"P Ranasinghe","year":"2017","unstructured":"Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the Asia-pacific region: a systematic review. BMC Public Health. 2017;17(1):101.","journal-title":"BMC Public Health"},{"key":"2162_CR19","unstructured":"World Bank. Sri Lanka. http:\/\/www.worldbank.org\/en\/country\/srilanka . Accessed 1 February 2017."},{"issue":"2","key":"2162_CR20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/S2056474000001756","volume":"14","author":"M Chandradasa","year":"2017","unstructured":"Chandradasa M, Kuruppuarachchi KALA. Child and youth mental health in post-war Sri Lanka. BJPsych Int. 2017;14(2):36\u20137.","journal-title":"BJPsych Int"},{"issue":"E33","key":"2162_CR21","first-page":"1","volume":"3","author":"M Chandradasa","year":"2016","unstructured":"Chandradasa M, Champika L, Gunathillaka K, Mendis J. Association of duration of untreated psychosis and functional level, in first episode of schizophrenia attending an outpatient clinic in Sri Lanka. J Postgrad Inst Med. 2016;3(E33):1\u20136. https:\/\/doi.org\/10.4038\/jpgim.8112 .","journal-title":"J Postgrad Inst Med"},{"issue":"3","key":"2162_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4038\/cmj.v58i3.6103","volume":"58","author":"A Hapangama","year":"2013","unstructured":"Hapangama A, Kuruppuarachchi KALA, Pathmeswaran A. Substance use disorders among mentally ill patients in a general hospital in Sri Lanka: prevalence and correlates. Ceylon Med J. 2013;58(3):111\u20135.","journal-title":"Ceylon Med J"},{"issue":"2","key":"2162_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4038\/sljpsyc.v5i2.7816","volume":"5","author":"N Edirisinghe","year":"2014","unstructured":"Edirisinghe N, Wijesinghe C, Williams S, Kuruppuarachchi KALA. Tobacco smoking in persons with schizophrenia followed up at a teaching hospital in Sri Lanka. Sri Lanka J Psychiatry. 2014;5(2):19\u201323.","journal-title":"Sri Lanka J Psychiatry"},{"issue":"5","key":"2162_CR24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1192\/bjp.182.5.455-a","volume":"182","author":"KALA Kuruppuarachchi","year":"2003","unstructured":"Kuruppuarachchi KALA, Williams SS. Betel use and schizophrenia. Br J Psychiatry. 2003;182(5):455.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"2162_CR25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4038\/sljpsyc.v7i1.8100","volume":"7","author":"M Chandradasa","year":"2016","unstructured":"Chandradasa M, Champika L, Amarasuriya M, Wijelakshman P, Bandara S, Ranaweera T, Fernando L. A comparative study of subjective experiences related to driving among outpatient psychotropic users and controls in Ragama, Sri Lanka. Sri Lanka J Psychiatry. 2016;7(1):23\u20135. https:\/\/doi.org\/10.4038\/sljpsyc.v7i1.8100 .","journal-title":"Sri Lanka J Psychiatry"},{"key":"2162_CR26","unstructured":"Jayathilake IS, Kuruppuarachchi KALA. A study on patient compliance with depot antipsychotic medication among schizophrenic patients attending the psychiatric clinics, Teaching Hospital, Ragama [abstract]. 27th Anniversary Academic Sessions, Postgraduate Institute of Medicine, University of Colombo, Colombo, Sri Lanka, October 2007. p. 21\u20132."},{"key":"2162_CR27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, Hr\u00f3bjartsson A, Mann H, Dickersin K, Berlin JA, Dor\u00e9 CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.","journal-title":"Ann Intern Med."},{"key":"2162_CR28","volume-title":"The ICD\u201010 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organization (WHO)","year":"1992","unstructured":"World Health Organization (WHO). The ICD\u201010 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva, Switzerland: WHO; 1992."},{"key":"2162_CR29","volume-title":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854","author":"World Health Organization (WHO)","year":"1995","unstructured":"World Health Organization (WHO). Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva, Switzerland: WHO; 1995."},{"key":"2162_CR30","first-page":"97","volume":"24","author":"JE Overall","year":"1988","unstructured":"Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull. 1988;24:97\u20139.","journal-title":"Psychopharmacol Bull."},{"key":"2162_CR31","unstructured":"Sri Lanka Medical Association. Sri Lanka Clinical Trials Registry. http:\/\/www.slctr.lk\/ . Accessed 1 February 2017."},{"issue":"5","key":"2162_CR32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1600-0447.2011.01814.x","volume":"125","author":"D Vancampfort","year":"2012","unstructured":"Vancampfort D, Knapen J, Probst M, Scheewe T, Remans S, De Hert M. A systematic review of correlates of physical activity in patients with schizophrenia. Acta Psychiatr Scand. 2012;125(5):352\u201362.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"2162_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00004850-200109000-00008","volume":"16","author":"M Letmaier","year":"2001","unstructured":"Letmaier M, Schreinzer D, Wolf R, Kasper S. Topiramate as a mood stabilizer. Int Clin Psychopharmacol. 2001;16(5):295\u20138.","journal-title":"Int Clin Psychopharmacol"},{"issue":"11","key":"2162_CR34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1192\/pb.23.11.686","volume":"23","author":"KALA Kuruppuarachchi","year":"1999","unstructured":"Kuruppuarachchi KALA, Rajakaruna RR. Psychiatry in Sri Lanka. Psychiatr Bull. 1999;23(11):686\u20138.","journal-title":"Psychiatr Bull"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2162-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T14:51:56Z","timestamp":1570114316000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2162-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2162-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2017,9,20]]},"article-number":"435"}}